ECM Therapeutics, Inc. licenses ECM technology from University of Pittsburgh Press Release: ECM Therapeutics, Inc. A Regenerative Medicine Company
Discovery of matrix bound nanovesicles within ECM bioscaffolds Huleihel L, et al. Sci Adv. 2016;2(6):e1600502.
ECM bioscaffolds used to repair volumetric muscle loss in human patients Dziki J, et al. Nat Regener Med 2016;1:16008.
Development of an ECM bioscaffold from esophageal mucosa Keane TJ, et al. Biomaterials. 2013 Sep;34(28):6729-37.
ECM bioscaffolds used to promote reconstruction of functional esophageal mucosa in human patients with esophageal adenocarcinoma Badylak SF, et al. Tissue engineering Part A. 2011;17(11-12):1643-50.
Development of ECM powder for tissue engineering applications Gilbert TW, et al. Biomaterials. 2005;26(12):1431-5.
Identification of matricryptic peptides derived from ECM bioscaffolds Li F, et al. Endothelium-Journal of Endothelial Cell Research. 2004;11(3-4):199-206.
Identification of antimicrobial activity associated with ECM bioscaffolds Sarikaya A, et al. Tissue engineering. 2002;8(1):63-71.
Identification of the Th2-restricted host response to ECM bioscaffolds Allman AJ, et al. Transplantation. 2001;71(11):1631-40.
ECM bioscaffolds used as a substrate for in vitro cell culture Badylak SF, et al. Journal of biomaterials science Polymer edition. 1998;9(8):863-78.
Identification of extractable growth factors from small intestinal submucosa Voytik-Harbin SL, et al. J Cell Biochem. 1997;67(4):478-91.
Development of ECM bioscaffolds using chemical and mechanical decellularization techniques Badylak SF, et al. Journal of Biomedical Materials research. 1995;29(8):977-85.